![Lucas_Mercanti_FinalUpdated_[3373]](https://wb65d28bwow3dv4kc1srch6a-wpengine.netdna-ssl.com/wp-content/uploads/2018/07/Lucas_Mercanti_FinalUpdated_3373.png)
May 4, 2020
INSIGHT: FDA Exclusivities Add Incentives to Covid-19 Drug Race By Steven D. Roth, Bloomberg Law, May 4, 2020 Drugmakers are racing to develop a treatment for […]
March 12, 2020
ELIGIBLE SUBJECT MATTER IN THE LIFE SCIENCES: Is the Conundrum Necessary By Irv N. Feit, Ph.D., March 10, 2020 One of the most difficult and controversial […]
March 10, 2020
Trademark Specimen Requirements to Demonstrate Use By Elizabeth Lee D’Amore, March 2020 Generally, an applicant is required to submit to the United States Patent and Trademark […]
March 3, 2020
It Is Not Fair to Leap Frog Expert Disclosure Requirements: An Analysis of HVLPO2 v. Oxygen Frog By David J. Galluzzo, IPWatchdog, March 3, 2020 “Properly […]
February 21, 2020
Lessons of Wisdom Following Athena SCOTUS Denial and October 2019 Patent Eligibility Guidance Update
Lessons of Wisdom Following Athena SCOTUS Denial and October 2019 Patent Eligibility Guidance Update By Jay S. Pattumudi, IP Watchdog, February 20, 2020 In view of the […]
February 12, 2020
Obtaining a reversal of a decision of the Patent Trial and Appeal Board in an inter partes review is statistically unlikely — under 23% in 2019. […]
July 13, 2019
Michael Mercanti Earns Ranking in Latest Edition of IAM Patent 1000 07/13/2019 | Lucas & Mercanti co-founder Michael Mercanti is recommended in the 2019 edition of […]
February 14, 2018
Lucas & Mercanti, LLP Names Two New Partners and Counsel, Expands Pharmaceutical Litigation Practice
Lucas & Mercanti, LLP Names Two New Partners and Counsel, Expands Pharmaceutical Litigation Practice 02/14/2018 | Lucas & Mercanti, LLP David J. Galluzzo and Steven D. […]
January 2, 2018
David James Galluzzo, Esq. is Now a Partner at Lucas & Mercanti, LLP 01/02/2018 New York, January 2, 2018: The partners of Lucas & Mercanti, LLP, […]